home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Reliable Test For BSE/vCJD Infection?

  March, 5 2001 10:06
your information resource in human molecular genetics
The BSE crisis that was once confined to the UK is spreading throughout Europe. Thousands of cattle are being slaughtered on the off-chance that they carry the disease. Worse still, scientists are unsure how many people are carrying the human form of the disease, vCJD. To prevent the widespread slaughter and to determine how many people are infected, what is needed is an effective diagnostic test for the deadly neurodegenerative prion.

Michael Clinton and colleagues at the Roslin Institute in Scotland may have the answer with the identification of a molecular marker for prion disease that is easily detectable in readily accessible tissues (Nature Medicine, Vol. 7, No.3, 01 Mar 2001). Based on the hypothesis that prions replicate in lymphoreticular organs-spleen, tonsils, appendix and lymph nodes-before they enter the CNS, the team examined these tissues. They detected a dramatic decrease in the RNA for a protein called erythroid differentiation-related factor (EDRF) in animals infected with a transmissible spongiform encephalopathy. However, the scientists do not know how this downregulation of erythroid activity relates to infection.

Prion expert Adriano Aguzzi discusses the findings in an accompanying News & Views article and the potential that EDRF will become a diagnostic marker for prion diseases.


Dr. Michael Clinton
Division of Gene Expression and Development,
Roslin Institute,
Scotland, UK
Tel: 44 01 31 527 4200
Fax: 44 01 31 440 0434
Email: michael.clinton@bbsrc.ac.uk

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.